SmartView Connect App - Implantable cardiac device management application software

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Available from:

Microport Crm Pty Ltd

Class:

Class III

Manufactured by:

MicroPort CRM S.r.l Via Crescentino sn, Saluggia, VC, 13040 Italy

Therapeutic area:

61680 - Implantable cardiac device management application software

Therapeutic indications:

The SmartView Connect application is part of the SmartView Remote Monitoring System (RMS), which is composed of the software itself installed on a off-the-shelf smartphone-like device and a back-office data management system controlled by MicroPort CRM. The purpose of the system is to remotely monitor MicroPort CRM implanted Bluetooth?-enabled pacemakers in patients? homes. The SmartView Connect App allows the remote monitoring of patients implanted with a MicroPort CRM Bluetooth? low energy-enabled pacemaker to treat symptomatic bradycardia. It is thus indicated in patients requiring atrial or ventricular pacing, or synchronous atrioventricular pacing.

Authorization status:

A

Authorization date:

2021-11-26